ArticleClinical and experimental medicine2025

Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblings.

Tyng-Wei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.